期刊文献+

Exendin-4对IL-1β诱导小鼠胰岛β细胞凋亡的保护作用 被引量:2

Protective Effect of Exendin-4 on Interleukin-1β-induced Apoptosis in Murine Pancreatic β-cells
暂未订购
导出
摘要 目的探讨GLP-1受体激动剂Exendin-4对细胞因子IL-1β诱导的小鼠胰岛β细胞株MIN6细胞凋亡的保护作用。方法体外培养小鼠胰岛β细胞株MIN6细胞,用不同浓度(5,10,20,40ng/mL)IL-1β作用24h,噻唑兰还原(MTT)法观察不同浓度IL-1β作用后细胞存活率;Hoechst-PI荧光染色法观测细胞凋亡形态;后以Exendin-4(100nmol/L)预处理细胞24h,观察Exendin-4对IL-1β诱导的MIN6细胞凋亡的保护作用。结果 MTT显示IL-1β(5~40ng/mL)作用24h后,MIN6细胞的增殖率明显下降,并呈现一定的量效关系;Hoechst-PI染色荧光显微镜检测证实随着IL-1β浓度的增高,MIN6细胞的凋亡率亦增加。Exendin-4预先处理24h后可以抑制IL-1β诱导的β细胞凋亡。结论 GLP-1受体激动剂Exendin-4可以显著抑制IL-1β诱导MIN6细胞的凋亡,提示Exendin-4对IL-1β诱导的MIN6细胞的凋亡具有保护作用。 Objective In the present study murine MIN6 pancreatic β-cells were employed to explore the protective effect of Exendin-4 on IL-1 β-induced apoptosis.Methods Murine MIN6 pancreatic β-cells were first treated with or without Exendin-4(100 nmol/L) for 24 hours,then they were incubated with different concentration of IL-1β(5,10,20,40 ng/mL)for another 24 hours.Cell viability was determined by MTT assay,and cells undergoing apoptosis were determined by fluorescence microscopy after Hoechst33342-propidium iodide staining.Results The proliferation of MIN6 cells was significantly inhibited after exposure to IL-1β with the concentrations ranging from 5 to 40 ng/mL for 24 h.Cell viability declined significantly(P0.01 compared with control group) when treated with IL-1β with the concentration over 10 ng/mL for 24 h.Pretreatment with Exendin-4,a long-acting GLP-1 receptor agonist,at the concentration 100 nmol/L for 24 h prior to exposure to IL-1β protected cells from IL-1β-induced apoptosis.Conclusion The results of our study indicate that Exendin-4 plays a protective role against IL-1β-induced apoptosis in MIN6 pancreatic β-cells.
出处 《福建医科大学学报》 2012年第1期7-10,共4页 Journal of Fujian Medical University
基金 福建省自然科学基金(2010J01162) 福建省卫生厅创新课题(2009-CX-4) 福建省卫生厅青年基金(2009-2-27)
关键词 白细胞介素1Β 胰岛 细胞凋亡 氨基酸类 毒液类 interleukin-1beta islets of langerhans apoptosis amino acids venoms
  • 相关文献

参考文献1

二级参考文献10

  • 1List JF, Habener JF. Glucagon-like peptide-1 agonists and the development and growth of pancreatic B-cells [J]. Am J Physiol Endocrinol Metab, 2004,286 :E875 - E881.
  • 2Hui H, Nourparvar A, Zhao X, et al. Glucagon-like- peptide-1 inhibits apoptosis of insulin-secreting cells via a cyclic 5'-adenosine monophosphate-dependent protein kinase A- and a phosphastidylinositol 3-kinase-dependent pathway [ J ]. Eudocrinology, 2003,144 : 1444 - 1455.
  • 3Kaneto H, Fujii J, Seo HG, et al. Apoptotic cell death triggered by nitric oxide in pancreatic beta-cells [ J ]. Diabetes, 1995,44:733 - 738.
  • 4Schreiber E, Matthias P, Mulh.r MM, et al. Rapid detection of oetamer binding proteill- with “miniextracts”, prepared from a small number of cells [ J ]. Nucl Acid Res, 1989,17:6419.
  • 5Baldwin AS Jr. Series introduction: the transcription factor NF-kappaB and human disease [ J ]. J Clin Invest, 2001,107:3 - 6.
  • 6McCabe C, Samali A, O' brien T. Beta cell cytoprotective strategies: establishing the relative roles for iNOS and ROS [ J]. Biochem Biophys Res Commun, 2006,342: 1240 - 1248.
  • 7Li L, El-Kholy W, Rhodes C J, et al. Glucagon-like peptide-1 protects beta cells from cytokine-indueed apoptosis and necrosis: role of protein kinase B [ J ]. Diabetologia, 2005,48 : 1339 - 1349.
  • 8Stoffers DA, Kieffer T J, Hussain MA, et al. Insulinotropic glucagons-like peptide 1 agonists stimulate expression of homeodomain protein IDX-1 and increase islet size in mouse pancreas [ J ]. Diabetes, 2000,49: 741 - 748.
  • 9Wang Q, Brubaker PL. Glucagon like peptide 1 treatment delays the onset of diabetes in 8 week old db/db mice [ J]. Diabetologia, 2002,45 : 1263 - 1273.
  • 10李强,许霖水.外源一氧化氮对大鼠胰岛细胞损伤机制研究[J].西北国防医学杂志,2002,23(5):361-363. 被引量:14

共引文献4

同被引文献18

  • 1Tabas I.The role of endoplasmic reticulum stress in the progression of atherosclerosis[J].Circ Res,2010,107(7):839-850.
  • 2Hattori Y,Jojima T,Tomizawa A.A glucagon-like peptide-1 (GLP-1) analogue,liraglutide,upregulates nitric oxide production and exerts anti-inflammatory action in endothelial cells[J].Diabetologia,2010,53(10):2256-2263.
  • 3Arakawa M,Mita T,Azuma K.Inhibition of monocyte adhesion to endothelial cells and attenuation of atherosclerotic lesion by a glucagon-like peptide-1 receptor agonist,exendin-4[J].Diabetes,2010,59(4):1030-1037.
  • 4Samani N J,vander Harst P.Biological ageing and cardiovascular disease[J].Heart,2008,94(5):537-539.
  • 5Cancel L M,Tarbell J M.The role of apoptosis in LDL transport through cultured endothelial cell monolayers[J].Atherosclerosis,2010,208(2):335-341.
  • 6Kaufman R J.Orchestrating the unfolded protein response in health and disease[J].J Clin Invest,2002,110(10):1389-1398.
  • 7Heller C,Kühn M C,Mülders-Opgenoorth B,et al.Exendin-4 upregulates the expression of Wnt-4,a novel regulator of pancreatic β-cell proliferation[J].Am J Physiol Endocrinol Metab,2011,301(5):E864-872.
  • 8Oeseburg H,de Boer R A,Buikema H,et al.Glucagon-like peptide 1 prevents reactive oxygen species-induced endothelial cell senescence through the activation of protein kinase A[J].Arterioscler Thromb Vasc Biol,2010,30(7):1407-1414.
  • 9Gaspari T,Liu H B,Welungoda I,et al.A GLP-1 receptor agonist liraglutide inhibits endothelial cell dysfunction and vascular adhesion molecule expression in an ApoE-/-mouse model[J].Diab Vasc Dis Res,2011,8(2):117-124.
  • 10DONATH MY. Islet inflammation in type 2 diabetes: frommetabolic stress to therapy[J]. Diabetes Care, 2008, 31(2): 161- 164.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部